Neuropace, Inc. Common Stock

NPCENASDAQUSD
15.36 USD
0.43 (2.72%)AT CLOSE (11:59 AM EDT)
14.85
0.51 (3.29%)
POST MARKET (AS OF 06:17 PM EDT)
Post Market
AS OF 06:17 PM EDT
14.85
0.51 (3.29%)
🔴Market: CLOSED
Open?$15.49
High?$15.68
Low?$15.01
Prev. Close?$15.79
Volume?130.0K
Avg. Volume?194.8K
VWAP?$15.22
Rel. Volume?0.67x
Bid / Ask
Bid?$13.10 × 100
Ask?$17.67 × 100
Spread?$4.57
Midpoint?$15.39
Valuation & Ratios
Market Cap?523.7M
Shares Out?34.0M
Float?22.0M
Float %?66.1%
P/E Ratio?N/A
P/B Ratio?36.23
EPS?-$0.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Employees
209
Market Cap
523.7M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-04-22
Address
455 N. BERNARDO AVENUE
MOUNTAIN VIEW, CA 94043
Phone: (650) 237-2700
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.38Strong
Quick Ratio?4.35Strong
Cash Ratio?0.91Adequate
Debt/Equity?4.08High
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
36.23HIGH
P/S?
5.26FAIR
P/FCF?
N/A
EV/EBITDA?
-34.4CHEAP
EV/Sales?
5.71FAIR
Returns & Efficiency
ROE?
-149.2%WEAK
ROA?
-21.8%WEAK
Cash Flow & Enterprise
FCF?$-9836000
Enterprise Value?$567.9M
Fundamentals ratios updated end of day